HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Federal Microbeads Law On The Books; FDA Eyes Tanning-Bed Restrictions; More

This article was originally published in The Rose Sheet

Executive Summary

President Obama signed the federal Microbead-Free Waters Act Dec. 29, putting an end to conflicting requirements for cosmetic microbead phase-outs at the state and local levels. More news in brief.

You may also be interested in...



CFI Sets Sights On US, Global Bans To ‘Close The Door’ On Cosmetic Animal Testing

California’s passage of the Cruelty-Free Cosmetics Act could trigger a state-level domino effect leading to a federal ban, according to Cruelty Free International’s North America Campaign Manager Monica Engebretson. Meanwhile, the NGO will continue to push for a global ban through the United Nations.

ECHA Requests Stakeholder Input On Microplastic Use; Possible Restrictions To Follow

The cosmetics industry likely will want to steer ECHA away from leave-on cosmetics and non-cleansing/exfoliating rinse-off products containing microplastic particles. NGOs and lawmakers in some European member states have called for microplastic bans that include those product categories, which would exceed prohibitions in the US and phase-outs voluntarily undertaken by industry.

PCPC Wants Cosmetics Reform Passed Before Threatened 'Blue Wave'

At the trade group's annual meeting in Palm Beach, Fla., leadership emphasized the importance of pushing cosmetics reform legislation over the finish line before November midterm elections. PCPC's support of a bipartisan proposal released by the Senate Health Committee largely hinges on preemption, the group indicated.

Related Content

Topics

UsernamePublicRestriction

Register

RS019817

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel